metastatic/advanced - colorectal cancer (mCRC) | endometrial cancer - (neo)adjuvant (NA) | |
endometrial cancer | endometrial cancer - (neo)adjuvant (NA) | |
pembrolizumab based treatment | ||
pembrolizumab plus lenvatinib | LEAP-001/ENGOT-en9 KEYNOTE-775 | |
pembrolizumab plus SoC | NRG-GY018_pMMR NRG-GY018_dMMR | KEYNOTE-B21 |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-